
REV 5901 is a competitive and orally active антагонист of leukotriene рецептор, with a Ki of 0.7 μM. REV 5901 is also a 5-lipoxygenase ингибитор. REV 5901 can be used for the research of asthma in which leukotriene release be involved.
REV 5901 is a competitive and orally active antagonist of leukotriene receptor, with a Ki of 0.7 μM. REV 5901 is also a 5-lipoxygenase inhibitor. REV 5901 can be used for the research of asthma in which leukotriene release be involved.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.